Using lower doses of semaglutide is cheaper for patients, results in fewer side-effects and helps ensure that stocks of the drug, which are still limited, go further. Tapering semaglutide 353 of the 2,246 patients (83% female, median age 49 years, median BMI 31.5, average body weight 92kg/14st 7lb) started to taper off semaglutide after they had reached their target weight
2025 [cited 3rd June 2025] CDSCO [Internet]
Clinical Eligibility and Medical Evaluation on Hers Hers typically requires patients to meet standard GLP-1 criteria: BMI 30 or 27 with weight-related comorbidities, stable cardiovascular health, no personal or family history of medullary thyroid carcinoma, and adequate renal function
Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid
CCL8, C-C motif chemokine ligand 8
Their lab markers such as insulin, CRP, triglycerides, told a story of rising inflammation
